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Introduction: Symposium on the Progress in Diabetic
Nephropathy
In the past decade since Kidney International first published
a collection of original research articles on diabetes mellitus and
the kidney [1] the magnitude of the problem has revealed itself
in the ever increasing population of diabetic patients entering
end-stage renal failure treatment programs. Thus, as a contrib-
utor to end-stage renal disease, diabetes exceeds all forms of
glomerulonephritis added together, and as a single cause, is
rivaled only by hypertension. That these sad facts underesti-
mate the enormity of the problem is reflected in the paper of
Damsgaard et al in this issue [21, in that the concordance of
serious kidney and macrovascular complications of diabetes
confers a much higher risk of cardiovascular mortality in
patients with microalbuminuria, before uremia ensues. In this
past decade the pace of research in diabetic nephropathy has
substantially quickened. Hopefully, this special edition of Kid-
ney International devoted to diabetic nephropathy presents an
accurate reflection of those ongoing scientific efforts which will
eventually contribute to improved approaches to prevention
and treatment of this growing public health problem.
Perhaps the linchpin of the understanding of diabetic
nephropathy is a clear delineation of the epidemiology and
natural history of the disorder. Hypothesis or experimental
observations which conflict with known clinical patterns must
be viewed with great skepticism. Thus, for example, it will be
important to unravel the factors contributing to the familial
aggregation of diabetic nephropathy risk [3], whether this is an
inherited predisposition, perhaps related to hypertension (in-
deed an area of intense debate which is represented by papers
in this issue) or due to familial clustering of noninherited risk
factors remains to be determined. It should be self-evident that
the clinical expressions of diabetic nephropathy would not
occur unless the specific and unique constellation of structural
abnormalities underlying this disease were far advanced. Al-
though much has been learned in the last decade regarding the
structural-functional relationships in diabetic nephropathy, this
remains an area of fruitful study, as reflected in this issue of
Kidney International. The universality of the effects of diabetes
on the kidney is documented in the paper of Hayashi et al [4],
indicating typical lesions of diabetic nephropathy in Japanese
patients with non-insulin dependent diabetes mellitus. How-
ever, as Parving et al point out [5], not all patients with diabetes
and proteinuria have diabetic nephropathy and, particularly
among type II patients without retinopathy, a high index of
suspicion for other renal diseases is warranted.
It is also clear that the aggregrate of structural abnormalities
which we call diabetic nephropathy represent increased produc-
tion, decreased breakdown, or both of renal extracellular
matrix components, thus resulting in their accumulation over
time. Papers reflecting new hypothesis as to the nature of the
biochemical derangements, new technologies for the study of
the regulation of matrix production in diabetes and new views
regarding fundamental glomerular chemistry are presented in
this collection of articles. These research directions are very
likely to be important in improving our understanding of the
genesis of the critical lesions of diabetic nephropathy and, thus,
in our ability to interfere with the early processes.
Diabetes is clearly a highly complex disturbance of the
body's internal milieu, and altered hormonal regulation could,
through hemodynamic perturbations, through more direct ef-
fects on extracellular matrix kinetics or through other mecha-
nisms, influence the rate at which the lesions of diabetic
nephropathy develop. A series of papers, two of them by Jaffa
et al [6] and Correa-Rotter et al [81 using newer molecular
biologic techniques, address these important directions.
Early functional disturbances of the kidney in diabetes have
long been recognized [1]. Several papers dealing with prognos-
tic significance of increased glomerular filtration rate and mi-
croalbuminuria continue the ongoing focus toward evolving
earlier, relatively non-invasive, markers and predictors of the
later development of serious renal disease and its associated
cardiovascular complications (Messent et al [7]). These studies
may also be pointing in important pathogenetic directions.
Further, these papers may change how we evaluate clinical
parameters in diabetic patients. Thus, Hansen et al indicate that
the ambulatory blood pressure measurements in microalbumin-
uric type I diabetic patients are more closely related to urinary
albumin excretion rates than are standard clinic visit blood
pressures [9].
The debate regarding the increased prevalence of abnormal-
ities of cation transport in diabetic patients with nephropathy is
well represented by the four papers dealing with this subject.
The ultimate resolution of these controversies will undoubtedly
accelerate our understanding of important pathogenetic factors.
The possibility that there are regional or racial differences in the
expression of these risk factors needs to be elucidated, Al-
though the paper by Elving et al [10] helps to resolve some of
the methodologic differences that have characterized this area,
uniformity in laboratory approaches will need to be adopted in
order for clarity to emerge.
Finally, there are seven papers dealing with treatment ap-
proaches in patients at risk for/or having developed diabetic
nephropathy. The first five of these papers wrestle with the
problem of the timing and nature of antihypertensive treatment
in animals and in humans with diabetes. The paper by Dahi-
JØrgensen et a! [Ill provides a continued hope that improve-
ment in blood sugar control can have a salutary influence on
kidney complications in diabetes. Finally, the paper by Cheung
et a! [12] reflects the improving technology of pancreas trans-
plantation for the uremic diabetic, but also considers the
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medical complexity of this procedure and, thus, its attendant
risks.
The editors of this section on diabetic nephropathy are
grateful to the authors for allowing their work to be published as
a component of this special edition of Kidney International
devoted to diabetic nephropathy. We are also most grateful to
the editors of Kidney International for providing the impetus,
space, and freedom for this project. It is hoped that these works
will stimulate further research, which is mandatory if we are to
develop new concepts and techniques necessary to diminish the
adverse impact of diabetic renal disease. It is also hoped that
the currently inadequate research funding resources directed at
the solution of this problem will increase to more appropriately
represent the magnitude of the impact of this disorder on the
well-being of the patients that we are pledged to serve.
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